Bliss GVS Pharma managing director resigns citing other commitments
Bliss GVS Pharma Ltd. announced the resignation of Gagan Harsh Sharma from his position as managing director, effective November 06, 2025. This decision, attributed to other professional commitments, was approved by the board of directors during a meeting held on November 06, 2025. Consequently, Sharma will also step down from the audit, corporate social responsibility, and risk management committees.
The resignation extends to all directorships and offices held within Bliss GVS Pharma’s subsidiary and associate companies, including Kremoint Pharma Pvt. Ltd., Bliss GVS International Pte Ltd, Asterisk Life Sciences Ghana Ltd, EPII Exports Pvt. Ltd., and Asterisk Lifesciences GBP Limited (UK). The company confirmed that Sharma is the spouse of Dr. Vibha Sharma, whole-time director, and brother-in-law of Mrs. Shruti Vishal Rao, also a whole-time director of the company.
The board meeting noted the resignation and initiated the necessary filings with regulatory bodies, including the Registrar of Companies and relevant stock exchanges. The company expressed gratitude for Sharma's contributions during his tenure.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Bliss GVS Pharma publishes news
Free account required • Unsubscribe anytime